rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2006-9-11
|
pubmed:abstractText |
Targeting persistent tubercule bacilli has become an important challenge in the development of anti-tuberculous drugs. As the glyoxylate bypass is essential for persistent bacilli, interference with it holds the potential for designing new antibacterial drugs. We have developed kinetic models of the tricarboxylic acid cycle and glyoxylate bypass in Escherichia coli and Mycobacterium tuberculosis, and studied the effects of inhibition of various enzymes in the M. tuberculosis model.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10329645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10523624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10572116,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10871608,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-10963578,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-11340206,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-11752250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-11815613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-12368431,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-12568740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-14681416,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-14681452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-14683609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-1530563,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-15608210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-15657047,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-15895072,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-16027371,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-2861202,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-6125497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-6389540,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-6813266,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-7126549,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-8206824,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9013556,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9488673,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9634230,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16887020-9927716
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1742-4682
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
27
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
|
pubmed:year |
2006
|
pubmed:articleTitle |
Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets.
|
pubmed:affiliation |
Bioinformatics Centre, University of Pune, Pune-411007, India. vivek@bioinfo.ernet.in
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|